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Abstract 40 
 41 
Beneficial microorganisms are widely used in agriculture for control of plant pathogens but a 42 
lack of efficacy and safety information has limited the exploitation of multiple promising 43 
biopesticides. We applied phylogeny-led genome mining, metabolite analyses and biological 44 
control assays to define the efficacy of Burkholderia ambifaria, a naturally beneficial bacterium 45 
with proven biocontrol properties, but potential pathogenic risk. A panel of 64 B. ambifaria 46 
strains demonstrated significant antimicrobial activity against priority plant pathogens. Genome 47 
sequencing, specialized metabolite biosynthetic gene cluster mining and metabolite analysis 48 
revealed an armoury of known and unknown pathways within B. ambifaria. The biosynthetic 49 
gene cluster responsible for the production of the metabolite, cepacin, was identified and 50 
directly shown to mediate protection of germinating crops against Pythium damping-off disease. 51 
B. ambifaria maintained biopesticidal protection and overall fitness in soil after deletion of its 52 
third replicon, a non-essential plasmid associated with virulence in B. cepacia complex bacteria. 53 
Removal of the third replicon reduced B. ambifaria persistence in a murine respiratory infection 54 
model. Here we show that by using interdisciplinary phylogenomic, metabolomic and functional 55 
approaches, the mode of action of natural biological control agents related to pathogens can be 56 
systematically established to facilitate their future exploitation.  57 
 58 
Main 59 
Numerous bacterial and fungal species have been recognised for their biological control abilities and 60 
plant growth-enhancing properties. Pesticides conventionally used in agriculture are under increasing 61 
scrutiny regarding their bioaccumulation and toxicity, which includes their fatal impact on pollinator 62 
species. Concern over chemical pesticides has reinvigorated research into biological control agents and 63 
their secreted bioactive compounds as viable natural alternatives for agriculture. One feature common to 64 
most biopesticidal species is their ability to secrete antimicrobial compounds into the environment and 65 
inhibit pathogenic microbes from causing crop disease. Bacteria within the genus Burkholderia are 66 
particularly diverse in their specialized metabolism and have a documented ability to produce a range of 67 
potent anti-bacterial, anti-nematodal and anti-fungal compounds1,2. They have demonstrated excellent 68 
promise as biological control agents with multiple strains used commercially as biopesticides until 1999. 69 
In common with other biological control genera such as Bacillus, Pseudomonas and Stenotrophomonas, 70 
certain Burkholderia species may also cause human, animal and plant infections. Therefore, in 1999 the 71 
US Environmental Protection Agency (EPA) placed a moratorium on new registrations of Burkholderia 72 
biopesticides unless such agents were defined as safe in terms of their risk of opportunistic infection2. 73 
 74 
Multiple species within the Burkholderia cepacia complex group were characterised or used as biological 75 
control agents2. They are highly active in their specialized metabolism, for example, producing antifungal 76 
compounds including pyrrolnitrin, occidiofungin, cepafungin and burkholdines; antibacterial bactobolins 77 
 
 
and enacyloxin IIa; and broader spectrum agents such as the cepacins3,4. Outside of the B. cepacia 78 
complex, other Burkholderia species also produce a range of antagonistic compounds. The bactobolins 79 
are also produced by Burkholderia thailandensis and Burkholderia pseudomallei and exhibit potent 80 
activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus5. 81 
Burkholderia gladioli also produces multiple antimicrobials including the anti-mycobacterial macrolide 82 
gladiolin6, its isomer lagriene7, the cytotoxic azapteridine toxoflavin8, and the polyyne caryoynencin9. 83 
There is no consensus on the distribution or co-occurrence of antimicrobial specialized metabolite 84 
encoding gene clusters in biopesticidal B. ambifaria, nor a holistic understanding of strain bioactivity and 85 
antimicrobial compound efficacy against priority bacterial10,11, fungal and oomycetal plant pathogens2. 86 
Biopesticidal activities have been descriptively characterised for individual producer strains against a 87 
panel of target organisms, or multiple producer strains against relatively few target organisms2. Previous 88 
studies have analysed the overall antagonistic properties of B. ambifaria, but none have examined the 89 
role of specific antimicrobial compounds in mediating biocontrol in natural soil microcosm models.  90 
 91 
To establish a biotechnological platform for biopesticidal use of B. ambifaria that considers its efficacy 92 
and safety, we systematically defined the genomic basis and functional efficacy of antimicrobial 93 
metabolites in 64 strains including 8 previously characterised biocontrol strains (Supplementary Table 94 
1). The strain collection examined included 58 environmental isolates recovered from multiple sources 95 
(soil, the maize, pea and grass rhizosphere, and leaves) and 6 strains isolated from the sputum of 96 
people with cystic fibrosis (CF). Collectively, it also represented strains recovered from various 97 
geographic origins (USA, Australia and Italy; Supplementary Table 1). The B. ambifaria core and 98 
accessory genome was revealed, and gene cluster network analyses were combined with antimicrobial 99 
activity assays to rationally understand the biopesticidal activity against crop pathogens. The role of 100 
individual antimicrobial metabolites in mediating crop protection was investigated using biosynthetic 101 
pathway mutants in non-sterile soil biocontrol models. Since curing of the B. cepacia complex third 102 
genomic replicon (c3) is possible in these multireplicon bacteria12, a B. ambifaria c3 mutant was 103 
constructed and shown to have reduced virulence in a murine respiratory infection model, yet retained 104 
its plant-protective properties. This work provides a foundation for developing targeted biological control 105 
agents and effective biocontrol products for reducing agricultural crop losses from bacterial, fungal and 106 
oomycete pathogens. 107 
 108 
Results: 109 
B. ambifaria genomics and in silico definition of specialized metabolite biosynthetic gene 110 
clusters 111 
To understand the genome-encoded potential of B. ambifaria as a biopesticide, phylogenomic and pan-112 
genomic analyses were applied (see Methods, Supplementary Figure 1, Supplementary Table 2 and 113 
Supplementary Notes). The three replicon genomic structure was present in 63 of the B. ambifaria 114 
strains analysed, while strain BCC1105 naturally lacked the third replicon. Contigs were scaffolded to 115 
one of three reference genomes to assemble complete genomes. The assembled genome sizes varied 116 
 
 
across the 64 strains, from 6.13 Mbp (BCC1105) to 8.03 Mbp (BCC1248), with a mean of 7.34 Mbp 117 
(Supplementary Table 2). Assembled replicons c1, c2 and c3 possessed a mean of 3.47 Mbp, 2.74 Mbp 118 
and 1.15 Mbp, respectively. Replicon c3 possessed the greatest variation in sequence capacity, 119 
whereas replicons c2 and c1 displayed greater consistency in size (Supplementary Table 2). A large B. 120 
ambifaria pan-genome was identified (22,376 distinct genes) of which 3784 genes comprised the core 121 
genome. The pan-genome represented a collection of genes approximately 3.4-fold greater than the 122 
mean B. ambifaria genome (6,546 genes). A large proportion of the accessory genome, 78.1% (14,582 123 
genes), was shared by less than 15% of the B. ambifaria strains. Exclusion of the strain which lacked the 124 
third replicon, BCC1105, from the core genome analysis resulted in the B. ambifaria core genome 125 
increasing from 3784 to 4166 genes. Three major clades were identified in the B. ambifaria 3784 core-126 
gene phylogeny (Figure 1A), and this established the evolutionary framework onto which the 127 
antimicrobial properties of each strain were overlaid using in silico and bioactivity approaches. In silico 128 
analyses of the 64 B. ambifaria genomes (see Methods, Supplementary Table 3 and Supplementary 129 
Notes) detected 1272 specialized metabolite biosynthetic gene clusters (BGCs), that were de-replicated 130 
into 38 distinct BGCs after Kmer-matching and gene topology comparisons (Figure 2; Supplementary 131 
Table 3). Network analysis was used to graphically summarise multiple attributes of the B. ambifaria 132 
BGCs including their biosynthetic diversity, strain distribution, and core or accessory nature within the 133 
species (Figure 2).  134 
 135 
Of the 38 distinct BGCs, 13 were previously characterised, and seven known to encode compounds with 136 
antimicrobial activity (Supplementary Table 4). Pyrrolnitrin13 was the only BGC for an antimicrobial 137 
metabolite found in all 64 B. ambifaria strains, whereas the BGC for the anti-Gram-negative metabolite 138 
enacyloxin IIa3 was the least common known antimicrobial BGC (Figure 2). Pyrrolnitrin and phenazine 139 
BGCs were encoded on replicon c2 and the remaining antagonistic compounds were encoded by BGCs 140 
on replicon c3. No known antimicrobial BGCs were identified on replicon c1. Barring a few exceptions, 141 
multiple antimicrobial encoding BGCs were associated with distinct clades within the B. ambifaria core-142 
gene phylogeny (Figure 1). Six of the seven clade 1b strains encoded the pathway responsible for 143 
enacyloxin IIa biosynthesis3. The more widely distributed burkholdine14 BGC was absent from all 144 
members of clade 2 and strain BCC1105, but all other strains possessed the anti-fungal biosynthetic 145 
locus. Bactobolin5 BGCs were concentrated in clade 1 and less frequently encountered in clade 2 and 3 146 
strains. Two strains, BCC1105 and BCC1224, only encoded the core anti-fungal metabolite pyrrolnitrin, 147 
and lacked any additional antimicrobial BGCs (Figure 1B). No single strain encoded all 7 previously 148 
known antimicrobial BGCs, however, approximately 59% of strains encoded four or more BGCs 149 
reflecting the known antimicrobial properties of B. ambifaria (Figure 1B).  150 
 151 
The silent nature of certain antimicrobial BGCs which are not expressed in standard laboratory cultures, 152 
including those in Burkholderia, is well established3,4. We therefore correlated in vitro metabolite 153 
production with BGC distribution. Ten B. ambifaria strains representing the seven characterised 154 
biocontrol strains and three additional strains from the broader species phylogeny (Figure 1A) were 155 
 
 
screened for metabolite production on agar growth media BSM-G3,15. Six known antimicrobial 156 
metabolites were detected by LC-MS (Supplementary Figure 2 and 3), five of which could be directly 157 
correlated to the presence of predicted BGCs (Table 1). Under these screening conditions the majority 158 
of BGCs (22 of 25) were biosynthetically active and produced the corresponding metabolite; individual 159 
strains encoding pyrrolnitrin, burkholdines and hydroxyquinolines BGCs were exceptions to this trend 160 
(Table 1). A sixth known metabolite, cepacin A16, was also detected in B. ambifaria J82 (BCC0191) by 161 
analytical analyses (see Methods) and subsequently correlated to a BGC (not recognised by antiSMASH 162 
v3)17 identified by searching for quorum sensing (QS) regulated BGCs (see below). 163 
 164 
Mapping direct antimicrobial activity against plant and animal pathogens 165 
Having established the presence of BGCs (Figures 1b and 2) and corresponding metabolites (Table 1), 166 
antagonism activity of the 64 B. ambifaria strains against priority plant10 and human pathogens 167 
(Supplementary Table 5) was evaluated as described3. The in vitro bioactivity was aligned against the 168 
core-gene phylogeny to map antagonism across B. ambifaria as a species (Figure 1c). A total of six 169 
strains lacked observable antimicrobial activity (Figure 1c). Clade 1a, 1b and 1c strains exhibited 170 
substantial bioactivity against Gram-negative pathogens, while only two strains outside these clades 171 
exhibited similar activity (Figure 1c). Clade 1b strains exhibited additional strong antagonistic activity 172 
towards Betaproteobacteria, Burkholderia multivorans and Alphaproteobacteria, Rhizobium radiobacter 173 
(Figure 1c), an activity not observed in other anti-Gram-negative B. ambifaria strains. The extended 174 
antimicrobial antagonism of clade 1b B. ambifaria correlated to the presence of the trans-AT PKS BGC 175 
for enacyloxin IIa (Figure 1b); all screened Gram-negative pathogens were susceptible to purified 176 
enacyloxin IIa with MICs ranging from 3.2 to 50 µg/ml (Supplementary Table 6). The additional anti-177 
Gram-negative activity correlated to the presence of the hybrid NRPS-PKS encoding BGC for bactobolin 178 
(Figure 1b). Anti-fungal (against Candida albicans, Fusarium solani and Alternaria alternata) and anti-179 
Gram-positive (against Staphylococcus aureus, Enterococcus faecalis and Bacillus subtilis) activity was 180 
more widespread than anti-Gram-negative activity in B. ambifaria, with 82% and 69% of tested strains 181 
(62 of 64) exhibiting these activities, respectively (Figure 1). Clade 2 B. ambifaria strains exhibited the 182 
least antimicrobial activity (5 of 9 lacking any in vitro observable activity) despite encoding BGCs for 183 
pyrrolnitrin, hydroxyquinolines, and cepacin (Figure 1b). 184 
 185 
A search for QS-regulated BGCs reveals the biosynthetic locus for the potent anti-oomycetal 186 
cepacin  187 
Multiple specialized metabolite BGCs are QS controlled3,4 and manipulation of this regulatory system 188 
has also been harnessed for Burkholderia metabolite discovery18. A search of luxR homologues within 189 
the B. ambifaria genomes was performed (see Supplementary Notes) and downstream of an 190 
uncharacterised LuxRI system (encoded by 22 of 64 strains) (Figure 3) was a conspicuous BGC 191 
encoding fatty acid desaturases, a beta-ketoacyl synthase and an acyl carrier protein (Figure 4a). 192 
Insertional mutagenesis of a fatty acyl-adenosine monophosphate (AMP) ligase-encoding gene, ccnJ, 193 
within this BCG was carried out in six B. ambifaria strain backgrounds (BCC0191, BCC1252, BCC1241, 194 
 
 
BCC0477, BCC1259 and BCC1218; Figure 1). The resulting mutants lacked anti-Gram-positive activity 195 
and the weak anti-Gram-negative activity, and showed considerably diminished growth inhibition of the 196 
oomycete Pythium ultimum (Figure 4b and Supplementary Figure 4). High resolution mass spectrometry 197 
of metabolite extracts from strain BCC0191 identified ions with m/z = 271.0964, corresponding to a 198 
predicted molecular formula of C16H14O4 consistent with cepacin A, a historically described Burkholderia 199 
polyyne16 of un-defined biosynthetic origin. Direct comparison with extracts from the originally reported 200 
cepacin A and cepacin B producer strain, “B. cepacia” ATCC 3935616 (taxonomically reclassified as a 201 
Burkholderia diffusa strain), confirmed that B. ambifaria BCC0191 produces cepacin A (Supplementary 202 
Figure 5). Cepacin A was absent in the B. ambifaria BCC0191::ccnJ cepacin insertional mutant (Figure 203 
4c), confirming that the uncharacterised LuxRI-associated BGC was responsible for the biosynthesis of 204 
this known Burkholderia metabolite. The cepacin A BGC is located on the second replicon of 22 B. 205 
ambifaria strains, with 100% and 56% presence in clade 3 and clade 2 strains, respectively (Figure 1b).  206 
 207 
Cepacin A is a key mediator of B. ambifaria biocontrol of Pythium ultimum damping-off disease 208 
B. ambifaria has been observed to inhibit P. ultimum and application to prevent crop damping-off 209 
diseases was a key trait in its historical biopesticide use2. However, the metabolites and/or BGCs which 210 
drive Burkholderia crop protection against Pythium-mediated damping-off have not been defined in a 211 
relevant biopesticide model, such as bacterial seed coating and planting in pathogen infested soil2. The 212 
cepacin-producer B. ambifaria BCC0191 exhibited strong biopesticidal activity when introduced as a P. 213 
sativum (pea) seed-coat to a P. ultimum biocontrol model in non-sterile soil (Figure 5a). Disruption of the 214 
cepacin BGC and application of the BCC0191 cepacin mutant as a seed coat reduced pea plant survival 215 
rates by more than 60% dependent on B. ambifaria seed coat inoculum level (105, 106 and 107 cfu/seed; 216 
Figure 5a). No biological control was observed when 105 cfu/seed of BCC0191 cepacin mutant was 217 
applied (<10% survival), compared to >50% protection mediated by the wild type at this level (Figure 218 
5a).  219 
 220 
A unique feature of the B. cepacia complex multi-replicon genome is that the third replicon is not 221 
essential and c3 deletion mutants lose virulence and antifungal phenotypes12. The cepacin BGC is 222 
located on the second c2 replicon of B. ambifaria and its biosynthesis was maintained when a third 223 
replicon deletion mutant, BCC0191∆c3, was constructed. Despite the loss of >1 Mb of DNA, the 224 
BCC0191∆c3 derivative remained competitive and biopesticidal in the Pythium-infested soil microbial 225 
community, protecting peas from damping-off at a rate marginally below that of the wild type (Figure 5b; 226 
the difference was not significant for a given inoculation size). The phenotypes of B. ambifaria BCC0191, 227 
its cepacin-deficient derivative (::ccnJ), c3 knockout mutant (∆c3), and combined cepacin-c3 mutation 228 
(::ccnJ∆c3) were tested further to understand the wider effect of these mutations on strain fitness (see 229 
Supplementary Notes). Antimicrobial activity against Gram-positive bacteria and Pythium was lost in the 230 
cepacin deficient mutant (Supplementary Figure 6). The BCC0191 c3 mutant lost antifungal activity but 231 
had a 2-fold increase in cepacin production enhancing its anti-Gram-positive antagonism 232 
(Supplementary Figure 6). Rhizocompetence was similar for the BCC0191 WT and BCC0191::ccnJ, but 233 
 
 
the third replicon deletion mutant colonised the pea rhizosphere at a significantly lower rate of 8.5 x 106 234 
cfu/g root (p = 0.027; Supplementary Table 7). 235 
 236 
A lack of understanding of safety and human pathogenicity were key reasons the US EPA placed a 237 
moratorium on B. cepacia complex biopesticides2. Since the BCC0191∆c3 mutant had retained its 238 
biopesticidal ability (Figure 5b), yet loss of this replicon is associated with reduced virulence in multiple 239 
infection models12, we assessed the pathogenicity of B. ambifaria BCC0191 and its c3 deletion mutant. 240 
In the Galleria mellonella wax-moth larvae model12, the deletion of the third replicon did not attenuate the 241 
virulence (Supplementary Figure 7a), showing that genes encoding significant insecticidal pathogenicity 242 
were not encoded on c3 in B. ambifaria strain BCC0191. In contrast, using a murine respiratory infection 243 
model relevant to chronic cystic fibrosis lung infections19,20, the persistence of B. ambifaria BCC0191 244 
was low and loss of the third replicon BCC0191∆c3 further reduced persistence in the lung 245 
(Supplementary Figure 7b and Supplementary Figure 7c). At an infective dose of 2 x 106 bacteria, the 246 
BCC0191 wild type persisted in the nasopharynx for the duration of the 5-day experiment but was 247 
cleared from lungs of 4 out of 6 mice by day 5. In contrast, the c3 mutant was rapidly cleared from both 248 
nasopharynx and lungs of mice (Supplementary Figure 8). Low numbers of the parental BCC0191 strain 249 
(<50 colonies) were detected in the lungs of mice after 5 days of infection, but BCC0191∆c3 was 250 
cleared within 48 hours. B. ambifaria (wild-type or c3 mutant) was not detected within the spleens of 251 
infected mice and no visible disease signs were observed throughout. Genotyping by PCR 252 
demonstrated that the low numbers of colonies recovered from the mouse infection model were either 253 
the administered B. ambifaria BCC0191 or BCC0191∆c3, respectively (Supplementary Figure 8).  254 
 255 
Discussion: 256 
Harnessing the potential of naturally biopesticidal bacteria is an important consideration if we are to keep 257 
pace with agricultural intensification and global food security. With increasing regulatory and 258 
environmental scrutiny of pesticides, the properties of natural agents will also have to be systematically 259 
defined before widespread use. Our in-depth genomic analysis of the intra-species diversity of B. 260 
ambifaria as a biopesticide and direct linkage of its specific metabolite, cepacin, to antagonism of 261 
Pythium and prevention of crop damping-off disease, sets a precedent on the mode of action of 262 
Burkholderia biopesticides. We have developed a holistic understanding of biopesticidal B. ambifaria, 263 
determining their pan-genomic content, extensive library of antimicrobial BGCs, efficacy in targeting key 264 
plant pathogens with specific antimicrobial metabolites, and defining the population biology of historically 265 
applied B. ambifaria biopesticides (see Supplementary Discussion). We have shown that biological 266 
control of damping-off disease in a relevant soil model is critically mediated by cepacin A, encoded on 267 
the second replicon of B. ambifaria. Since effective biological control of Pythium also occurs in the 268 
absence of the third replicon, which has been characterised as a Burkholderia virulence plasmid12, we 269 
have highlighted this as an attenuation strategy for developing potentially safe biopesticide strains which 270 
retain biotechnological efficacy. 271 
 
 
 272 
Discovery of cepacin biosynthetic gene cluster 273 
Mining and phylogenetically clustering the LuxR protein sequences from 64 B. ambifaria genomes 274 
revealed multiple solo and luxI-associated luxR genes, and these were linked with both known and 275 
uncharacterised specialized metabolite BGCs. In addition to the B. ambifaria encoded enacyloxin3 and 276 
bactobolin5 BGCs, LuxR regulation of other specialised metabolite BGCs has been further described 277 
within and outside the genus. Burkholderia thailandensis synthesises the quorum sensing regulated 278 
cytotoxic compound malleilactone21, and pyocyanin production in Pseudomonas aeruginosa is controlled 279 
by a hierarchical QS network22. This approach was initially intended to understand the role of quorum 280 
sensing regulation in B. ambifaria biopesticidal specialized metabolism, but serendipitously led to the 281 
identification of the cepacin A BGC. 282 
 283 
Cepacins A and B were initially described as metabolites of Burkholderia cepacia, formally 284 
Pseudomonas cepacia16,23, with the original producer strain now classified as B. diffusa24. Both polyyne 285 
metabolites displayed strong anti-Staphylococci activity, while cepacin A showed weak anti-Gram-286 
negative activity16. Cluster K, a gene cluster with 76.9% homologous nucleotide similarity spanning 12.9 287 
kbp (in addition to 8.4 kbp of non-homologous regions) to the B. ambifaria cepacin A BGC was identified 288 
in Collimonas fungivorans Ter331 using nucleotide BLAST (Supplementary Figure 9). The C. 289 
fungivorans cluster K has been linked to the biosynthesis of the anti-fungal polyyne collimomycin25 290 
whose BGC organisation (Supplementary Figure 9) and chemical formula (C16H18O4) resemble cepacin 291 
A (C16H14O4). Recent characterisation of this C. fungivorans strain showed it produces a range of 292 
polyynes, collectively designated the collimonins26, with collimonin A showing the most structural 293 
similarity to cepacin A. Several key differences in gene content were identified between the cepacin and 294 
collimonin BGCs in the regions flanking the core biosynthetic genes (Supplementary Figure 9). C. 295 
fungivorans cluster K contains genes encoding four additional hypothetical proteins, a major-facilitator 296 
superfamily transporter and fatty acid desaturase; whereas the B. ambifaria cepacin BGC encoded one 297 
extra hypothetical protein. An unusual feature of the cepacin and collimonin BGC variants is the 298 
substitution of the associated regulatory genes that comprise a QS-associated luxRI in Burkholderia and 299 
a lysR regulator in Collimonas (Supplementary Figure 9). Similar proteins to those identified in the 300 
cepacin BGC are listed in Supplementary Table 8. 301 
 302 
Cepacin A is a major component of B. ambifaria biological control 303 
We have demonstrated the importance of cepacin A in the context of biological control of the major crop 304 
family Fabaceae (Pisum sativum). Disruption of the cepacin BGC in B. ambifaria significantly reduced 305 
plant survival beyond germination and emergence compared to the wild-type (Figure 5a; p < 0.05). The 306 
contribution of specific metabolites to biocontrol has been studied extensively in Pseudomonas 27 307 
relative to other characterised biocontrol genera. The anti-fungal properties of pyrrolnitrin and 2,4-308 
diacetylphloroglucinol have been evidenced as important metabolites in the biological control of several 309 
fungal pathogens, on a diversity of crops, in a range of Pseudomonas species and strain backgrounds27. 310 
 
 
Other studies have highlighted the in vitro antimicrobial activity, and presence of the corresponding 311 
specialized metabolite BGCs or protective effects in field trials in Bacillus28 and Streptomyces29, but fail 312 
to define the impact of distinct metabolites in a biocontrol system. This study establishes the role of 313 
cepacin A as the major bioactive component of the B. ambifaria armoury in the biocontrol of damping-off 314 
disease by P. ultimum in a relevant non-sterile soil model. The reduced protection against P. ultimum of 315 
the cepacin A-deficient mutant compared to the wild-type B. ambifaria also indirectly confirms the 316 
expression of the cepacin A BGC in planta (Figure 5b).  317 
 318 
There has been considerable discussion on whether Burkholderia species known to cause opportunistic 319 
infections can be safely exploited for environmental benefit30. Multiple species in the recently defined 320 
Paraburkholderia genus have not been associated with infection, are generally environmental, and 321 
mediate plant-beneficial interactions30. Transfer of biopesticidal properties such as the B. ambifaria 322 
cepacin BGC to Paraburkholderia species is a potential route to future safe usage. Attenuation of 323 
pathogenicity in biopesticidal strains is an alternative means to facilitate their biotechnological 324 
exploitation. Third replicon deletion in B. ambifaria BCC0191 led to loss of persistence in the murine lung 325 
infection model (Supplementary Figure 7b and 7c), and hence provides an unmarked means of 326 
attenuating pathogenicity but preserving biopesticidal potential in this strain (see Supplementary 327 
Discussion, Figure 5). In addition, the BCC0191∆c3 mutant also showed a reduced root colonisation 328 
after 14 days compared to the wild type (see Supplementary Discussion, Supplementary Table 7), 329 
suggesting it has less potential for bioaccumulation, which is another desirable trait for a biopesticide. 330 
Whether c3 deletion is sufficient to render B. ambifaria as a species completely avirulent remains to be 331 
fully determined. B. ambifaria is rarely found in CF lung infections, with a survey of US patients from 332 
1997 to 2007 implicating it collectively with several other B. cepacia complex species as causing <3% of 333 
all Burkholderia cases31. A 2017 survey of Burkholderia infections in 361 UK CF patients did not find B. 334 
ambifaria at all32. This epidemiological data combined with the low murine respiratory persistence of B. 335 
ambifaria (Supplementary Figure 7b and Supplementary Figure 7c) compared to virulent pathogens 336 
such as P. aeruginosa19,20, suggests that B. ambifaria has low pathogenicity. From this start point, 337 
attenuation of virulence using unmarked c3 deletion as performed herein, combined with further 338 
essential gene mutation strategies as used to construct live bacterial vaccines, could also provide a 339 
route towards the development of safe B. ambifaria biopesticides. 340 
 341 
Conclusion: 342 
Biological control agents have been applied to crops with success in the past, but no in-depth genomic 343 
or analytical chemistry analyses have been conducted on individual species to assess their biocontrol 344 
potential. This study demonstrated the benefits of using genome mining and in vitro antimicrobial 345 
screening to define BGCs that contribute to biocontrol, and enable their use in the rational design of 346 
future bacterial biopesticides. The potential of cepacin-producing B. ambifaria in protecting economically 347 
relevant crop species from attack by oomycete pathogens has been demonstrated. It is clear that B. 348 
 
 
ambifaria has accumulated multiple plant protective BGCs that underpin its historical exploitation as a 349 
biopesticide2. With an urgent need to sustain crop protection and agricultural production, yet reduce use 350 
of environmentally persistent chemical pesticides, systematically repurposing natural biological control 351 
agents such as B. ambifaria for biotechnology is a timely alternative solution.  352 
 353 
Methods: 354 
 355 
Genome sequencing and replicon assembly 356 
Genomes used in this study were either sequenced as part of this study or downloaded from public 357 
databases. 125-nucleotide and 150-nucleotide paired-end reads were generated for 60 B. ambifaria 358 
genomes (Supplementary Table 1) using an Illumina HiSeq 2000 and HiSeq X Ten, respectively. 359 
Illumina adaptors were trimmed, read quality assessed and contigs assembled as described in the 360 
Supplementary Notes. Genomic contigs were re-arranged and scaffolded into replicons by mapping the 361 
contigs against three reference genomes using CONTIGuator v2.7.433. The option to fill gaps using 362 
strings of “N” was disabled. Reference genomes were B. ambifaria AMMD (SAMN02598309) and B. 363 
ambifaria MC40-6 (SAMN02598385), both obtained from the European Nucleotide Archive; the third 364 
reference, B. ambifaria BCC0203, was generated using Pacific Biosciences single molecule real time 365 
sequencing. The replicons were manually assessed for any scaffolding errors and corrected when 366 
necessary. Completed replicons (c1, c2 and c3) were re-circularised based on genes dnaA, parA and 367 
parB, respectively, using the software Circlator v1.2.134. The species validity of B. ambifaria dataset was 368 
defined by calculating the average nucleotide identity (ANI) shared between all available B. ambifaria 369 
genomes using PyANI v0.2.135. Two sequenced strains from this study (BCC1630 and BCC1638) and 370 
one publically available strain (RZ2MS16) were excluded from the dataset, using a 95% ANI species 371 
threshold36. The remaining 64 B. ambifaria strains along with mutant derivatives used in this study are 372 
listed in the supplementary data (Supplementary Table 1). 373 
 374 
Genome mining and specialized metabolite BGC network analysis 375 
All bioinformatics analyses were performed using the Cloud Infrastructure for Microbial Bioinformatics 376 
(CLIMB) computing resource37. Scaffolded replicons and non-scaffolded contigs were annotated using 377 
Prokka v1.12-beta38. Bioinformatics tool antiSMASH v.3.0.517 detected specialized metabolite BGCs in 378 
both scaffolded and non-scaffolded contig sequences. Known pathways that were not detected by 379 
antiSMASH were identified with nucleotide-nucleotide BLAST v2.6.0+39. BGCs were dereplicated by 380 
clustering nucleotide sequences using pairwise Kmer-matching software Mash v1.1.140; reporting a 381 
maximum p-value and maximum distance of 1 and 0.05, respectively. The resulting distance matrix was 382 
visualized with Cytoscape v3.4.041, applying the Jaccard index, p-value and Mash distance (estimated 383 
mutation rate between sequences) as edge attributes. Duplicated edges between nodes and self-loops 384 
were removed from the network analysis. The resulting cluster network was further refined by comparing 385 
 
 
the gene topologies of pathway representatives from network clusters of the same specialized 386 
metabolite class; and splitting or merging network clusters where necessary. 387 
 388 
Genomic analysis and phylogenomics 389 
The core and accessory genome of the collective 64 B. ambifaria strains was calculated using Roary 390 
v3.7.042 using a 95% minimum percentage identity for blastp, and core gene threshold of 99% 391 
occurrence across the 64 strains. The core gene alignment generated by Roary was used to construct 392 
an approximate-maximum-likelihood core-gene phylogeny with double-precision FastTree v2.1.943. The 393 
root position was determined by including the outgroup species Burkholderia vietnamiensis G4 394 
(PRJNA10696) (Supplementary Figure 10). Once the root branch point was defined, a second tree was 395 
constructed using RAxML v8.2.1144 with General Time Reversible (GTR) substitution and a GAMMA 396 
model of rate heterogeneity supported by 100 bootstraps. 397 
 398 
Culture conditions and antimicrobial activity screens 399 
All B. ambifaria strains were grown in tryptic soy broth (TSB) at 37°C and aerated overnight, unless 400 
stated otherwise. The 64 B. ambifaria strains were screened for production of antimicrobials with 401 
antagonistic activity against 14 plant, animal and human pathogens, and other reference species 402 
(Supplementary Table 5). A standard overlay assay was used to screen for antimicrobial activity, as 403 
previously described3, with the amendment of using 400 μl overnight (O/N) culture of the susceptibility-404 
testing organism per 100 ml half-strength iso-sensitest agar. A strain was considered antagonistic if the 405 
zone of inhibition was >10 mm in diameter. Antagonism assays with A. alternata and F. solani involved 406 
the re-suspension of mycelia in 1 ml PBS from 9-day old cultures grown in 50 mm petri dishes on potato 407 
dextrose agar; 320 μl of mycelial resuspension was used per 100 ml half-strength iso-sensitest agar 408 
before pouring as an overlay. 10x10 cm square Petri dishes containing basal salts medium15 409 
supplemented with 4 g/l glycerol (BSM-G)3 were used to screen six isolates concomitantly, and a 410 
replicator used to transfer the bacterial culture onto the agar surface from 96-well plates. B. ambifaria 411 
strains were grown on BSM-G for three days at 30°C. Each 96-well plate stored six strains tested for 412 
antimicrobial activity, with 200 μl O/N culture grown in TSB broth (Oxoid) per used well, and DMSO at a 413 
final concentration of 8% for -80°C storage. Following chloroform-killing, approximately 25 ml of 414 
antimicrobial susceptibility test organism-seeded half-strength iso-sensitest agar was poured over each 415 
10x10 cm square Petri dish. The plates were incubated at the optimum temperatures of each 416 
susceptibility-test organism (Supplementary Table 5). The heatmap of pathogen antagonism was 417 
created in statistics software R v3.2.3 via RStudio v0.99.484. 418 
 419 
Confirmation of the Burkholderia cepacin A BGC-metabolite link 420 
Insertional mutagenesis was used to disrupt the expression of the cepacin A pathway. Primers were 421 
designed to amplify a 649 bp region of the fatty AMP ligase-encoding gene (Supplementary Table 9), 422 
yielding a final product of 707 bp. The product was amplified using the Taq PCR Master Mix Kit 423 
(Qiagen), and ligated into the suicide vector pGp-omega-Tp45 following restriction with XbaI and EcoRI 424 
 
 
(NEB). The resulting construct was transformed into competent Escherichia coli SY327 via heat-shock 425 
(maintained by trimethoprim selection; 50 μg/ml), and subsequently introduced into B. ambifaria via tri-426 
parental mating with E. coli HB101 carrying the helper plasmid pRK2013 (kanamycin selection, 50 427 
μg/ml). The transconjugants were selected using trimethoprim 150 μg/ml and polymyxin 600 U/ml. The 428 
presence and correct location of the insertional vector was confirmed by PCR. Comparative-HPLC and 429 
antimicrobial activity screens between the wild-type and insertional mutant confirmed the disruption of 430 
the cepacin BGC. 431 
 432 
Construction and phenotypic analysis of a B. ambifaria BCC0191∆c3 mutant 433 
The B. ambifaria BCC0191∆c3 mutant was constructed following the methods outlined in Agnoli et al. 434 
201212. This involved using the pMiniC3 vector, a 12.6 kb plasmid constructed from the origin of 435 
replication of the B. cenocepacia H111 third replicon and containing its repA, parB, and parA genes, and 436 
trimethoprim resistance and sucrose counter selection cassettes12. In brief, the pMiniC3 vector was 437 
mated into the BCC0191 wild-type to displace the native c3 replicon via a tri-parental mating involving 438 
the donor E. coli MC1061 pMiniC3, recipient B. ambifaria BCC0191 and E. coli HB101 carrying the 439 
helper plasmid pRK2013. B. ambifaria BCC0191 pMinic3 clones were subsequently cured of pMinic3 by 440 
sucrose counter-selection. B. ambifaria BCC0191∆c3 clones were screened for the absence of both 441 
replicon c3 and plasmid pMinic3 by PCR using the DreamTaq Green PCR Master Mix (2X) (Thermo 442 
Scientific) (Supplementary Table 9). The virulence of B. ambifaria BCC0191 and its ∆c3 mutant was 443 
evaluated in G. mellonella wax moth larvae12 and murine chronic lung19,20 infection models as described 444 
below.  445 
 446 
Detection of LuxR homologues as specialized metabolite regulators 447 
LuxR-encoding gene homologues were identified by replicating the systematic in silico approach 448 
previously described46. In brief, a Hidden Markov Model was built to identify potential LuxR-encoding 449 
genes; and these candidates were annotated for encoded protein domains. Candidate genes were 450 
considered LuxR-encoding if all four conserved LuxR protein domains were detected. The extracted 451 
amino acid sequences were aligned using MAFFT v7.305b47 and a phylogenetic tree generated using 452 
FastTree v2.1.943. The regulatory function of the luxR gene was inferred either from the literature or 453 
genes with putative functions starting within 5 kbp upstream and downstream of the luxR gene. 454 
 455 
Culture conditions, extraction protocol and high resolution mass spectrometry 456 
All B. ambifaria strains were grown at 30°C on BSM-G. The original cepacin producer, strain ATCC 457 
395396, was obtained from the Belgium Coordinated Collection of Microorganisms where it is deposited 458 
as B. diffusa strain LMG 24093. Single plates were extracted by addition of 4 ml of acetonitrile for 2 459 
hours, followed by centrifugation to remove debris. Crude extracts were directly analysed by UHPLC-460 
ESI-Q-TOF-MS. UHPLC-ESI-Q-TOF-MS analyses were performed using a Dionex UltiMate 3000 461 
UHPLC connected to a Zorbax Eclipse Plus C-18 column (100 × 2.1 mm, 1.8 μm) coupled to a Bruker 462 
MaXis II mass spectrometer. Mobile phases consisted of water (A) and acetonitrile (B), each 463 
 
 
supplemented with 0.1% formic acid. A gradient of 5% B to 100% B over 30 minutes was employed at a 464 
flow rate of 0.2 ml/min. The mass spectrometer was operated in positive ion mode with a scan range of 465 
50-3000 m/z. Source conditions were: end plate offset at −500 V; capillary at −4500 V; nebulizer gas 466 
(N2) at 1.6 bar; dry gas (N2) at 8 L min−1; dry temperature at 180 °C. Ion transfer conditions were: ion 467 
funnel RF at 200 Vpp; multiple RF at 200 Vpp; quadrupole low mass at 55 m/z; collision energy at 5.0 468 
eV; collision RF at 600 Vpp; ion cooler RF at 50–350 Vpp; transfer time at 121 μs; pre-pulse storage 469 
time at 1 μs. Calibration was performed with 1 mM sodium formate through a loop injection of 20 μL at 470 
the start of each run. 471 
 472 
Biocontrol of Pythium ultimum using a Pisum sativum model 473 
The infestation of soil with Pythium ultimum Trow var. ultimum (MUCL 16164) was developed from the 474 
methodology proposed in Toda et al. 201548. Plugs of P. ultimum were grown at approximately 22°C on 475 
potato dextrose agar (PDA) for three days. Infested soil was produced by mixing the surface mycelia 476 
from the PDA agar plates into a 5:1 compost:sand mixture (one-90 mm PDA petri per 120 g soil), and 477 
incubating the soil at approximately 22°C for three days. Potting mix was composed of 1% (w/w) 478 
Pythium-infested soil in unsterilised non-infested soil, or 100% unsterilised non-infested soil for a non-479 
infested control. Unsterilised P. sativum seeds (Early Onward cultivar) were coated with B. ambifaria 480 
before planting. B. ambifaria coating suspension was produced as follows: an overnight (approximately 481 
18 hours) TSB culture of B. ambifaria was washed in sterile 1x volume phosphate buffer solution (PBS) 482 
and re-suspended in sterile 0.5x volume PBS. The suspension was adjusted to 10x 0.5 OD at 600 nm 483 
(approximately 109 cfu/ml), and either applied at the neat concentration or diluted to achieve the desired 484 
inoculum levels (108 and 107 cfu/ml). Control P. sativum seeds lacking the B. ambifaria coating were 485 
dipped in PBS. P. sativum plants were grown at 22°C with a 16-h light/8-h dark photoperiod (70% RH) 486 
for 14 days, and watered as required. Groups of ten seeds per inoculum and seed coat organism were 487 
assayed per experiment, and the experiment was performed in triplicate. Significant differences between 488 
BCC0191 wild-type and mutant derivatives was assessed using two tailed t-test or Welch’s two tailed t-489 
test. Two tailed t-test assumptions were normally distributed data (Shapiro-Wilk test) and equal 490 
variances (Bartlett test); Welch’s two tailed t-test did not assume equal variances. 491 
 492 
Metabolite extraction and HPLC analysis 493 
To confirm the absence of cepacin A in the BGC mutants constructed for the different B. ambifaria strain 494 
backgrounds (BCC0191, BCC1252, BCC1241, BCC0477, BCC1259 and BCC1218; Supplementary 495 
Figure 3), each strain was grown on BSM-G agar for three days at 22oC, the bacterial growth removed 496 
and an equal amount of agar (a 2 cm disc) extracted with 0.5 ml ethyl acetate for 2 hours at room 497 
temperature. This was fractionated on an acetonitrile gradient (5% to 95%) using a Waters® 498 
AutoPurification™ HPLC System fitted with a reverse phase analytical column (Waters® XSelect CSH 499 
C18, 4.6 x 100 mm, 5 μm). Metabolites eluted from the column were detected by a photodiode array and 500 
the peak corresponding to cepacin A identified by its retention time in relation to the LC-MS confirmed 501 
presence of the polyyne in this fraction.  502 
 
 
 503 
In vivo killing assay using Galleria wax moth larvae 504 
Galleria mellonella wax moth larvae were sourced from BioSystems Technology Ltd TruLarv (Exeter, 505 
UK). Bacterial cultures of BCC0191 wild-type and BCC0191∆c3 were grown overnight (approximately 18 506 
hours) in TSB broth at 37°C, washed and re-suspended in 1x volume PBS before being adjusted to 507 
approximately 1x106 cfu/ml. Larvae were injected in the hindmost proleg on the right-side of the 508 
abdomen. Each larva was injected with 10 µl aliquots of B. ambifaria BCC0191 wild-type and 509 
BCC0191∆c3 bacterial suspensions with a 25G x 1” needle (BD Microlance 3) using a 1705TLL, 50 µL 510 
syringe (Hamilton). PBS injections were included as controls. Each condition included ten larvae, and 511 
the experiment was performed in triplicate over three days. The larvae were incubated at 37°C for 72 512 
hours, and their survival status was monitored at 18, 24, 42, 48, 66 and 72 hours post-inoculation. 513 
Larvae were recorded as dead when they failed to respond to physical agitation. The total viable count 514 
of the bacterial suspensions was calculated during the first and third replicate via drop-count. The mean 515 
average cfu/ml of BCC0191 wild-type and BCC0191∆c3 suspensions were 1.5x106 cfu/ml and 1.0x106 516 
cfu/ml, respectively. 517 
 518 
Murine chronic lung infection model. A murine respiratory infection model as used for modelling P. 519 
aeruginosa pathogenicity was applied to B. ambifaria essentially as described19,20. All experiments were 520 
carried out at the University of Liverpool with approval from the UK Home Office and University ethics 521 
committee. Randomisation of mice to cages (experimental groups) was performed by animal unit staff 522 
with no role in study design as described19. An initial dosing experiment demonstrated good tolerance of 523 
an infectious dose of 106 B. ambifaria, equivalent to that used for P. aeruginosa in previous studies19,20. 524 
Sample size was calculated to give 95% power at alpha 0.05 to detect a >4-fold difference in lung CFU 525 
between BCC0191 and BCC0191∆c3, assuming mean CFU of 100 in BCC0191 lung and a standard 526 
deviation of 50% of the mean (as determined in preliminary experiments). Groups of 6 mice (female 527 
BALB/c, 6-8 weeks old; Charles River, UK) were infected intranasally under anaesthesia 528 
(O2/isolfuorane), achieving an actual dose of 2 x 106 B. ambifaria BCC0191 or its third chromosome 529 
replicon mutant BCC0191∆c3. Symptoms of disease were monitored, and mice culled at 24 hours, 48 530 
hours and 5 days post infection. Researchers were not blinded to the experimental groupings. The 531 
nasopharyngeal tissue, lungs and spleens were removed, homogenised in 3 ml PBS, serial dilutions 532 
prepared and plated onto Burkholderia cepacia selective agar (Oxoid, UK) for enumeration of surviving 533 
B. ambifaria. No animals were excluded from the analysis. Colonies from the tissue of mice carrying 534 
infection were confirmed to be strain B. ambifaria BCC0191 by Random Amplified Polymorphic DNA 535 
typing (RAPD; see Supplementary Figure 8). 536 
 537 
Rhizocompetence of B. ambifaria BCC0191 WT and derivatives 538 
The rhizocompetence of B. ambifaria BCC0191 and its derived mutants were evaluated essentially as 539 
described49. Liquid cultures of BCC0191, BCC0191::ccnJ and BCC01911∆c3 were grown in TSB broth 540 
overnight at 37°C (50 µg/ml trimethoprim for BCC0191::ccnJ), then washed and re-suspended in 1x 541 
 
 
volume PBS and adjusted to 1x109 cfu/ml. Pisum sativum (pea) seeds were coated in the bacterial 542 
suspensions and planted in a potting mix composed of 5:1 multi-purpose compost to sand. The seeds 543 
were germinated and grown at 22°C with a 16 hour light - 8 hour dark photoperiod (70% RH) for 14 days 544 
and watered as required. After 14 days the plants were removed, and excess soil shaken from the root 545 
systems. The 1st – 2nd cm of root was excised, macerated in 1 ml PBS, and serially diluted. Dilutions of 546 
the root suspension were plated onto Burkholderia cepacia selective agar (BCSA; Oxoid UK) and 547 
incubated at 37°C for 24 hours to calculate total viable counts. Three plants were used per strain 548 
derivative, and three un-inoculated seeds included as a control. Any growth from the control plants was 549 
subject to RAPD PCR profiling to distinguish the bacteria from B. ambifaria. Non-B. ambifaria growth on 550 
the control plates was discounted from the total viable counts. Total viable counts were standardised to 551 
1 g fresh weight of root. 552 
 553 
 554 
Data Availability 555 
Sequence data that support the genomic findings of this study have been deposited in the European 556 
Nucleotide Archive with the accession/bioproject codes listed in Supplementary Table 1. The data that 557 
support the antimicrobial production, P. sativum and G. mellonella survival, and murine infection model 558 
findings of this study are available from the corresponding authors upon request. Bacterial strains and 559 
constructs will be made available upon written request to the corresponding authors and after signing a 560 
Material Transfer Agreement. We are restricted in re-distributing certain bacterial strains such as those 561 
from recognised culture collections, but such requests will be re-directed to the appropriate source.  562 
 563 
Code Availability 564 
The publicly available software and codes used for genome sequence determination, phylogenomics, 565 
mass spectrometry and general statistical analysis are described in the appropriate Method sections. 566 
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Table 1. Correlation of BGC presence and in vitro metabolite production in B. ambifaria1 604 
B. ambifaria strain (clade) Pyrrolnitrin Burkholdines Hydroxyquinolines Bactobolins Enacyloxin IIa Cepacins
2
 BGC Metabolite BGC Metabolite BGC Metabolite BGC Metabolite BGC Metabolite BGC Metabolite 
Characterised biocontrol 
strains             
ATCC 53267 / BCC0284 (1d) + + + + - - - - - - - - 
ATCC 53266 / BCC0338 (1d) + - + - - - - - - - - - 
BC-F / BCC0203 (1b) + + + + - - + + + + - - 
AMMD / BCC0207 (1b) + + + + + - - - + + - - 
Ral-3 / BCC0192 (2) + + - - + + + + - - + - 
J82 / BCC0191 (3) + + + + - - - - - - + + 
M54 / BCC0316 (3) + + + + - - - - - - + + 
Other strains:             
BCC1100 (1a) + + + + - - + + - - - - 
BCC1105 (1c) + + - - - - - - - - - - 
BCC1220 (2) + + - - + + - - - - + - 
 605 
Footnotes: 606 
1Grey cells highlight BGCs in specific strains where the corresponding metabolite was not detected. 607 
2The metabolite cepacin was detected prior to identification of its biosynthetic gene cluster. 608 
 
 
Figure legends 609 
 610 
Figure 1. Core-gene phylogeny of 64 B. ambifaria strains (a) aligned with presence/absence grid of known 611 
antimicrobial specialized metabolite BGCs (b) and antimicrobial activity heatmap (c). (a) The phylogenetic 612 
tree was constructed based on 3784 core genes identified and aligned using the software Roary. The root was 613 
determined using a secondary tree containing an outgroup species, Burkholderia vietnamiensis G4 614 
(Supplementary Figure 10). Six clades were defined in the phylogeny, however, strains BCC1066 and MEX-5 615 
branched outside these clades. Strains subject to further LC-MS analysis are highlighted in bold; strains with 616 
historical biocontrol usage are indicated with an asterisk. RAxML was used to construct the maximum-likelihood 617 
phylogeny using the generalised time reversible (GTR) model with a GAMMA substitution (100 bootstraps). Nodes 618 
with bootstrap values <70% are indicated with black circles. The evolutionary distance scale bar represents the 619 
number of base substitutions per site. (b) The presence of the eight characterised anti-fungal and antibiotic gene 620 
clusters: pyrrolnitrin, burkholdine, AFC-BC11, hydroxyquinolines, cepacin A, bactobolins, phenazine and 621 
enacyloxin IIa in the 64 B. ambifaria strains are ordered by phylogenetic position. Matrix generated using 622 
Phandango50. (c) The antimicrobial activity of 62 B. ambifaria strains were defined by measuring the diameter of 623 
the zones of inhibition (mm); n = 2 overlays of each B. ambifaria strain against each susceptibility organism. 624 
Heatmap shows mean zone of inhibition. Strains MEX-5 and IOP40-10 were not available for the antimicrobial 625 
production assay. 626 
 627 
Figure 2. Specialized metabolite BGC network analysis of 64 B. ambifaria strains. A total of 1,272 BGCs were 628 
detected across the 64 strains, and dereplication indicated these represented 38 distinct BGCs (38 distinct network 629 
clusters). Nucleotide sequences were clustered using Mash and visualized with Cytoscape. This network analysis 630 
was used to provide a visual summary of the breadth of B. ambifaria BGCs including their biosynthetic diversity, 631 
strain distribution, and core or accessory nature within the species. Each node represents a specialized metabolite 632 
BGC extracted from a single B. ambifaria strain. Node colours represent specialized metabolite classes, and 633 
numbers correspond to the number BGC examples (nodes) of each distinct BGC (network cluster). Core BGCs 634 
were defined as BGCs that occurred in >98% of B. ambifaria strains. Characterised BGCs known in the literature 635 
are labelled. BGCs responsible for pyrrolnitrin, AFC-BC11 and hydroxyquinolines biosynthesis are classified as 636 
Other (O) by antiSMASH but represent different metabolite classes not recognised by antiSMASH. 637 
 638 
Figure 3. Unrooted phylogeny of LuxR protein homologues extracted from 64 B. ambifaria strains. 639 
Branches were labelled with characterised quorum sensing systems or putative/confirmed LuxR regulatory 640 
functions based on the literature and annotated flanking genes starting within 5 kbp upstream and/or downstream 641 
of the luxR gene. The number of strains encoding distinct LuxR homologues is indicated in brackets. A total of 356 642 
homologues were identified across the 64 strains, representing 14 distinct LuxR protein clades. FastTree was used 643 
to construct the approximate-maximum-likelihood phylogeny using the generalised time reversible substitution 644 
model. The evolutionary distance scale bar represents the number of base substitutions per site.  645 
 646 
Figure 4. Organization of the cepacin A biosynthetic gene cluster, LC-MS analysis of cepacin A production 647 
and antimicrobial screening of B. ambifaria BCC0191 wild-type (WT) and cepacin A deficient derivative 648 
(::ccnJ). (a) Organisation and putative function of genes within the cepacin A BGC; further annotation details are 649 
provided in Supplementary Figure 9. The insertion site of the vector used during mutagenesis is highlighted by the 650 
 
 
inverted yellow triangle. (b) Zones of inhibition against S. aureus NCTC 12981, P. carotovorum LMG 2464 and P. 651 
ultimum Trow var. ultimum MUCL 16164 by BCC0191 WT and BCC0191::ccnJ. Scale bar represents 20 mm. n = 3 652 
biological replicates. Images were converted to greyscale, brightness decreased by 20%, and contrast increased 653 
by 20%. (c) Extracted ion chromatograms at m/z = 293.08 ± 0.02, corresponding to [M + Na]+ for cepacin A, from 654 
LC-MS analyses of crude extracts from agar-grown cultures of BCC0191 WT (top) and the BCC0191::ccnJ mutant 655 
(bottom); n = 3 independent LC-MS analyses of WT and mutant cultures. (d) Structure of cepacin A, the identity of 656 
which was confirmed by comparison to an authentic standard from a known producer (Supplementary Figure 3). 657 
 658 
Figure 5. Biological control of Pythium damping-off disease is mediated by B. ambifaria cepacin. (a) Pea 659 
germination (14 days) in P. ultimum infested soil observed for groups of 10 seeds coated with 10
7
, 10
6
 and 10
5
 cfu, 660 
respectively, of BCC0191 wild-type (WT) and BCC0191::ccnJ. The overall percentage survival of germinating peas 661 
treated with the WT and BCC0191::ccnJ B. ambifaria strains is shown on the right of panel A. Survival was 662 
assessed as plants that had stems >30 mm in height after 14 days. Plant survival was significantly different at 663 
every inoculum level between BCC0191 WT and BCC0191::ccnJ, as indicated by two-sided t-test or Welch’s two-664 
sided t-test (* = p < 0.05; ** = p < 0.01); significant difference (left to right) p = 0.002, p = 0.03, p = 0.002 with 95% 665 
confidence interval. n = 10 seeds per condition (seed coat) and dosage (cfu/seed), repeated in triplicate. Centre 666 
bar represents mean, and error bars represent standard error. (b) Pea germination (14 days) in P. ultimum infested 667 
soil observed for groups of 10 seeds coated with 10
7
, 10
6
 and 10
5
 cfu, respectively, of BCC0191 WT and 668 
BCC0191∆c3. The overall percentage survival of germinating peas treated with BCC0191 WT and BCC0191∆c3 is 669 
shown on the right of panel B. No significant difference (left to right: p = 0.22, p = 0.22, p = 0.16), as determined by 670 
two-sided t-test with 95% confidence interval, in plant survival between BCC0191 WT and BCC0191∆c3 at all 671 
inoculum levels. n = 10 seeds per condition (seed coat) and dosage (cfu/seed), repeated in triplicate. Centre bar 672 
represents mean, and error bars represent standard error.  673 
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